World Carvana Buying Brick-And-Mortar: Investing Insight
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
Articles — Page 1812
Higher Yield Consistent Dividend: Choosing VIG or FDVV
Looking for a higher yield consistent dividend or steady dividend growth? This in-depth guide compares VIG and FDVV, ...
Defense Stocks Rise Iran: What Investors Need to Know
Geopolitical tensions involving Iran can shift the defense landscape fast. This guide explains how to spot potential ...
What Best Artificial Intelligence Stocks to Buy Now
AI momentum is reshaping markets. This guide dives into what best artificial intelligence stocks to buy now, how to s...
Plot Twists That Changed Finances in a Moment
A single moment can flip your financial world—from an overlooked 401(k match to a surprise medical bill. These 10 plo...
Hong Kong’s RedotPay Eyes Funding Ahead of U.S. IPO
Hong Kong’s RedotPay is exploring a fundraising round of up to $150 million ahead of a potential U.S. IPO, according ...
Oncology Institute (TOI) Earnings: A Deep Dive for Investors
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
Technology (Maps) 2025 Earnings: WM MAPS Outlook Guidance
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
Stock Market Today, March: Nebius Group Raises $3.75B
A sharp move in Nebius Group after announcing a massive capital raise highlights how debt and potential dilution can ...
Stock Market Today, March: Markets Edge Higher as Fed Opens
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
Dell Workforce Shrinks Third: Cost Cuts Hit Headcount
Dell Technologies reports a 10% decline in global staff for the third consecutive year, trimming roughly 11,000 jobs ...
ClearPoint Neuro (CLPT) Earnings Outlook for Investors
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...